Aortic function is compromised in a rat model of polycystic ovary syndrome

Human Reproduction

Volumn 21, Issue 3, 2006, Pages 651-656

  Lakhani, Kalpana ^a   Yang, Wenxuan ^b   Dooley, Audrey ^b   El Mahdi, Essam ^b   Sundaresan, Maryse ^a   McLellan, Susan ^b   Bruckdorfer, Richard ^b   Leonard, Andrew ^b   Seifalian, Alexander ^b   Hardiman, Paul ^b  

^a NORTH MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Animal model; Polycystic ovaries; Ultrasound; Vascular system

Indexed keywords

ACETYLCHOLINE; MIFEPRISTONE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA DISEASE; ARTICLE; BLOOD VESSEL COMPLIANCE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HYPOTHESIS; IN VITRO STUDY; IN VIVO STUDY; MATERNAL HYPERTENSION; NONHUMAN; OVARY POLYCYSTIC DISEASE; RAT; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; VASCULAR ENDOTHELIUM; VASCULAR RING;

ANIMALIA;

EID: 33644853484     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dei399     Document Type: Article

References (48)

1. Andersen HL, Weis JU, Fjalland B and Korsgaard N (1999) Effect of acute and long-term treatment with 17 beta-estradiol on the vasomotor responses in rat aorta. Br J Pharmacol 126,159-168.
2. Balletshofer BM, Rittig K, Stock J, Lehn-Stefan A, Overkamp D, Dietz K and Haring H (2003) Insulin resistant young subjects at risk of accelerated atherosclerosis exhibit a marked reduction in peripheral endothelial function early in life but not differences in intima-media thickness. Atherosclerosis 171,303-309.
3. Conway GS, Agrawal R, Betteridge DJ and Jacobs HS (1992) Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol (Oxf) 37,119-125.
4. Costarella CE, Stallone JN, Rutecki GW and Whittier FC (1996) Testosterone causes direct relaxation of rat thoracic aorta. J Pharmacol Exp Ther 277,34-39.
5. 2+ entry mechanisms of coronary vasoconstriction. Arterioscler Thromb Vasc Biol 19,1034-1040.
6. De Vries MJ, Dekker GA and Schoemaker J (1998) Higher risk of preeclampsia in the polycystic ovary syndrome: A case control study. Eur J Obstet Gynecol Reprod Biol 76,91-95.
7. Duckitt K and Harrington D (2005) Risk factors for pre-eclampsia at antenatal booking: Systematic review of controlled studies. BMJ 330,565-572.
8. Elting MW, Korsen TJ and Schoemaker J (2001) Obesity, rather than menstrual cycle pattern or follicle cohort size, determines hyperinsulinaemia, dyslipidaemia and hypertension in ageing women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 55,767-776.
9. Ge ZD and He GW (2000) Comparison of University of Wisconsin and St Thomas' Hospital solution on EDHF-mediated function in coronary micro-arteries. Transplantation 70,22-31.
10. Glusa E, Gräser T, Wagner S and Oettel M (1997) Mechanisms of relaxation of rat aorta in response to progesterone and synthetic progestins. Maturitas 28,181-191.
11. Goetz RM, Morano I, Calovini T, Studer R and Holtz J (1994) Increased expression of endothelial constitutive nitric oxide synthase in rat aorta during pregnancy. Biochem Biophys Res Commun 205,905-910.
12. Hu S, Seifalian AM and Hardiman P (2004) Cardiovascular function in pregnant women with polycystic ovary syndrome. Fertil Steril 82,S84-S84.
13. Huang A, Sun D, Koller A and Kaley G (1998) Gender difference in flow-induced dilation and regulation of shear stress: Role of estrogen and nitric oxide. Am J Physiol 275,R1571-R1577.
14. Isomaa B (2003) The major health hazard: The metabolic syndrome. Life Sci 73,2395-2441.
15. Jeremy JY and Dandona P (1986) Inhibition by hydrocortisone of prostacyclin synthesis by rat aorta and its reversal with RU486. Endocrinology 119, 661-665.
16. Kannel WB and McGee DL (1979) Diabetes and cardiovascular disease: The Framingham Study. J Am Med Assoc 241,2035-2038.
17. Kelly C, Spiers A, Gould G, Petrie J, Lyall H and Connell J (2003) Altered vascular function in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 87,742-746.
18. Lakhani K, Seifalian AM and Hardiman P (2002) Impaired carotid viscoelastic properties in women with polycystic ovaries. Circulation 106,81-85.
19. Lakhani K, Seifalian AM and Hardiman P (2003) Evidence of atherosclerosis in young women with polycystic ovary syndrome. Hum.Reprod 18(Suppl 1),25.
20. Lakhani K, Leonard AJ, Seifalian AM and Hardiman P (2005) Microvascular dysfunction in women with polycystic ovary syndrome. Hum Reprod, in press.
21. Li H and Forstermann U (2000) Nitric oxide in the pathogenesis of vascular disease. J Pathol 190,244-254.
22. Mather KJ, Verma S, Corenblum B and Anderson TJ (2000) Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome. J Clin Endocrinol Metab 85,1851-1856.
23. Mukerji MS, Leathard HL and Huddart H (2000) The effect of progesterone on spontaneous and agonist-evoked contractions of the rat aorta and portal vein. J Pharm Pharmacol 52,843-849.
24. Oltman CL, Gutterman DD, Scott EC, Bocker JM and Dellsperger KC (1997) Effects of glycosylated hemoglobin on vascular responses in vitro. Cardiovasc Res 34,179-184.
25. Palmer RM, Ferrige AG and Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor. Nature 327,524-526.
26. Paradisi G, Steinberg H, Shepard M, Hook G and Baron A (2003) Troglitazone therapy improves endothelial function near normal levels in women with polycystic ovary syndrome. Clin Endocrinol Metab 88,576-580.
27. Philibert D (1984) An original multifaceted antihormone in vivo. In Agarwal MK (ed) Adrenal Steroid Antagonism. Walter de Gruyter & Co, Berlin, Germany, pp 77-101.
28. Plutzky J (2003) The vascular biology of atherosclerosis. Am J Med 115(8A), 55S-61S.
29. Poston L and Taylor PD (1995) Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Clin Sci (Lond) 88,245-255.
30. Reaven GM (2002) Metabolic syndrome: Pathophysiology and implications for management of cardiovascular disease. Circulation 106,286-288.
31. Redman CW and Sargent IL (2005) Latest advances in understanding preeclampsia. Science 308,1592-1594.
32. Ruiz A, Aguilar R, Tébar M, Gaytán F and Sánchez-Criado JE (1996) RU486 treated rats show endocrine and morphological responses to therapies analogous to responses in women with polycystic ovary syndrome treated with similar therapies. Biol Reprod 55,1284-1291.
33. Ruiz A, Tébar M, Pérez-Romero A, Rol de Lama MA and Sánchez-Criado JE (1997) Serum levels of GH, IGF-1,LH and ovarian steroids in cyclic and RU 486 treated rats. J Endocrinol Invest 20,611-615.
34. Sampaio-Moura MJ and Marcondes FK (2001) Influence of estradiol and progesterone on the sensitivity of rat thoracic aorta to noradrenalin. Life Sci 68,881-888.
35. Sánchez-Criado JE, Bellido C, López FJ and Galiot F (1992) Antiprogesterone RU 486 induces dissociation of LH and FSH secretion in the cyclic rat: Effect of anti-inhibin serum. J Endocrinol 134,43-49.
36. Sánchez-Criado JE, Tébar M, Sánchez A and Gaytán F (1993) Evidence that androgens are involved in atresia and anovulation induced by antiprogesterone RU486 in rats. J Reprod Fertil 99,173-179.
37. Selles J, Polini N, Alvarez C and Massheimer V (2002) Nongenomic action of progesterone in rat aorta: Role of nitric oxide and prostaglandins. Cell Signal 14,431-436.
38. Shimokowa H, Flahavan NA and Vanhoutte PM (1989) Natural course of the impairment of endothelium-dependent relaxations after balloon endothelium removal in porcrine coronary arteries: Possible dysfunction of a pertussis toxin-sensitive G-protein. Circ Res 65,740-753.
39. Shimokowa H, Yasutake K, Fujii MK, Owada R, Nakaike Y and Takayanagi T (1996) The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol 28,703-711.
40. Spaanderman ME, Willekes MD, Hoeks AP, Ekhart TH and Peeters LL (2000) The effect of pregnancy on the compliance of large arteries and veins in healthy parous control subjects and women with a history of preeclampsia. Am J Obstet Gynecol 183,1278-1286.
41. Steinberg HO, Ckaker H, Leaming R, Johnson A, Brechtel G and Baron AD (1996) Obesity/insulin resistance is associated with endothelial dysfunction. J Clin Invest 97,2601-2610.
42. Talbott EO, Guzick D, Sutton-Tyrrell K, McHugh-Pemu KP, Zborowski JB, Remsberg KE and Kuller LH (1995) Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 15,821-826.
43. Teoh H, Leung SW, Quan A, Huang M, Man GS and Man RY (2000) Acetylcholine-mediated relaxation in rat thoracic aorta is enhanced following acute exposure to physiological concentrations of 17beta-estradiol. Mol Cell Biochem 207,65-70.
44. Tep-areenan P, Kendall DA and Randall MD (2003) Mechanisms of vasorelaxation to testosterone in the rat aorta. Eur J Pharmacol 465,125-132.
45. Wallerath T, Witte K, Schafer SC, Schwarz PM and Prellwitz W (1999) Down-regulation of the expression of endothelial NO synthase in likely to contribute to glucocorticoid-mediated hypertension. Proc Natl Acad Sci USA 96,13357-13362.
46. Williams SB, Cusco JA, Roddy MA, Johnstone MD and Creager MA (1996) Impaired nitric oxide-mediated vasodilation in patients with non-insulin dependent diabetes. J Am Coll Cardiol 27,567-574.
47. 2/pCO2 monitoring system in comparison with near-infrared spectroscopy. Liver Int 23,163-170.
48. Zhang M, Wang GJ, Benishin CG and Pang PKT (2002) Rapid effect of progesterone on the contraction of rat aorta in-vitro. J Pharm Pharmacol 54,1529-1534.